Article info

Download PDFPDF

4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line
Free

Authors

Citation

Touris-Lores M, Busto-Iglesias M, García-Quintanilla L, et al
4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line

Publication history

  • First published March 23, 2023.
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.